City

Amiens (1)

London (1)

Rome (1)

Shanghai (1)

Overall Status

Recruiting (2)

Completed (1)

Unknown status (1)

Phase

n/a (1)

Sponsor

Centre Hospitalier Universitaire, Amiens (1)

Fudan University (1)

Lawson Health Research Institute (1)

Regina Elena Cancer Institute (1)

Collaborator

Central Hospital Saint Quentin (1)

Hamilton Health Sciences Corporation (1)

Harbin Medical University (1)

Lega Italiana per la Lotta contro i Tumori (1)

Liaoning Tumor Hospital & Institute (1)

London Health Sciences Centre (1)

University of California, San Diego (1)

Intervention

blood retriewal (1)

capecitabine-irinotecan combination (1)

hpv-associated oropharyngeal cancer (1)

none- observational study (1)

radiation (1)

Study Documents

Intervention Type

biological (1)

diagnostic test (1)

drug (1)

other (1)

radiation (1)

Funder Type

Other (4)

Study Type

Observational (3)

Interventional (1)

predictive biomarkers

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HPV-associated Oropharyngeal Cancer

Recruiting

PREDICTIVE BIOMARKERS
+2 more

HPV-ASSOCIATED OROPHARYNGEAL CANCER

Rome, Italy

"Regina Elena" National Cancer Institute

Oct 19, 2023

Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

Recruiting

Immunotherapy
+5 more

blood retriewal

Amiens, Picardie, France

CHU Amiens Picardie

Apr 3, 2023

Neoadjuvant Chemoradiotherapy for Rectal Cancer

Unknown status

Rectal Neoplasm Malignant Carcinoma
+4 more

Radiation
Capecitabine-Irinotecan Combination

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center

Jan 11, 2020

Circulating Tumor Cells & Circulating Endothelial Cells as

Completed

Clear Cell Renal Cancer
+4 more

None- observational study

London, Ontario, Canada

London Health Sciences Centre

Dec 20, 2019